Royalty Pharma Cash from Financing (TTM) Trends

Royalty Pharma PLC (RPRX)

28.00 -0.11 (-0.39%) USD | NASDAQ | Apr 26, 16:00

28.00 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-2.149B
September 30, 2023	-2.182B
June 30, 2023	-1.053B
March 31, 2023	-934.26M
December 31, 2022	-944.86M
September 30, 2022	-877.38M
June 30, 2022	386.98M
March 31, 2022	390.82M
December 31, 2021	385.11M

Date	Value
September 30, 2021	305.79M
June 30, 2021	-1.086B
March 31, 2021	717.98M
December 31, 2020	1.487B
September 30, 2020	1.479B
June 30, 2020	1.555B
March 31, 2020	-334.15M
December 31, 2019	-1.192B

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-2.182B

Minimum

Sep 2023

1.555B

Maximum

Jun 2020

-237.90M

Average

-334.15M

Median

Mar 2020

Cash from Financing (TTM) Benchmarks